Equities

Zivo Bioscience Inc

Zivo Bioscience Inc

Actions
  • Price (EUR)0.00
  • Today's Change0.00 / --
  • Shares traded-1.00
  • 1 Year change-100.00%
  • Beta--
Data delayed at least 15 minutes, as of Oct 27 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. It is developing a product candidate targeting poultry gut health. It is developing products for Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. It is focused on licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers.

  • Revenue in USD (TTM)63.37k
  • Net income in USD-7.08m
  • Incorporated1983
  • Employees8.00
  • Location
    Zivo Bioscience Inc21 E. Long Lake Road, Suite 100BLOOMFIELD HILLS 48304United StatesUSA
  • Phone+1 (248) 452-9866
  • Websitehttps://zivobioscience.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.